Page last updated: 2024-08-16

propafenone and quinidine

propafenone has been researched along with quinidine in 95 studies

Research

Studies (95)

TimeframeStudies, this research(%)All Research%
pre-199025 (26.32)18.7374
1990's29 (30.53)18.2507
2000's28 (29.47)29.6817
2010's9 (9.47)24.3611
2020's4 (4.21)2.80

Authors

AuthorsStudies
Topliss, JG; Yoshida, F1
Gao, F; Lombardo, F; Shalaeva, MY; Tupper, KA1
Gao, F; Lombardo, F; Obach, RS; Shalaeva, MY2
Pajeva, IK; Wiese, M1
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL1
Lombardo, F; Obach, RS; Waters, NJ1
Artursson, P; Bergström, CA; Hoogstraate, J; Matsson, P; Norinder, U; Pedersen, JM1
Adrián, F; Anderson, P; Brinker, A; Caldwell, JS; Chatterjee, A; Gray, NS; Henson, K; Janes, J; Kato, N; Kuhen, K; Matzen, JT; McNamara, C; Nagle, A; Nam, TG; Plouffe, D; Schultz, PG; Trager, R; Winzeler, EA; Yan, SF; Zhou, Y1
Alimuddin, M; Bulloch, D; Dahl, R; Grant, D; Lee, N; Peacock, M1
Ahlin, G; Artursson, P; Bergström, CA; Gustavsson, L; Karlsson, J; Larsson, R; Matsson, P; Norinder, U; Pedersen, JM1
Chen, L; He, Z; Li, H; Liu, J; Liu, X; Sui, X; Sun, J; Wang, Y; Zhang, W1
Cooper, J; Cui, Y; Fink, M; Gavaghan, DJ; Heath, BM; McMahon, NC; Mirams, GR; Noble, D; Sher, A1
Caradonna, NP; Hallifax, D; Houston, JB; Turlizzi, E; Zanelli, U1
Barnes, SW; Bonamy, GM; Bopp, SE; Borboa, R; Bright, AT; Chatterjee, A; Che, J; Cohen, S; Dharia, NV; Diagana, TT; Fidock, DA; Froissard, P; Gagaring, K; Gettayacamin, M; Glynne, RJ; Gordon, P; Groessl, T; Kato, N; Kuhen, KL; Lee, MC; Mazier, D; McNamara, CW; Meister, S; Nagle, A; Nam, TG; Plouffe, DM; Richmond, W; Roland, J; Rottmann, M; Sattabongkot, J; Schultz, PG; Tuntland, T; Walker, JR; Winzeler, EA; Wu, T; Zhou, B; Zhou, Y1
Fijorek, K; Glinka, A; Mendyk, A; Polak, S; Wiśniowska, B1
Dalvie, D; Loi, CM; Smith, DA1
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ1
Bellman, K; Knegtel, RM; Settimo, L1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1
Arnold, E; De Clercq, E; Fang, Z; Feng, D; Kang, D; Liu, X; Pannecouque, C; Pilch, A; Ruiz, FX; Sun, Y; Wang, Z; Wei, F; Zhan, P; Zhao, T1
Bertagnin, C; Du, R; Guizzo, L; Hou, L; Huang, B; Jia, R; Ju, H; Kang, D; Kong, X; Li, P; Liu, X; Loregian, A; Ma, X; Murugan, NA; Poongavanam, V; Zhan, P; Zhang, Y1
Castro, I; de Brito, FS; Maia, IG; Pereira, MH1
Baĭer, T; Brakhmann, I; Khilbel, T; Kiubler, V; Shmitt, K; Valdeker, B1
Lu, F; Mei, BY; Zhang, XM1
Deiwick, M; Konertz, W; Scheld, HH; Weyand, M1
Brusca, A; Comba Costa, G; Gaita, F; Gaschino, G; Greco, C; Richiardi, E; Rosettani, E1
Benz, I; Kohlhardt, M2
Hansen, JF; Madsen, JK; Nielsen, H; Rasmussen, V; Sørum, C1
Gillis, AM; Keashly, R1
Cohen, JM; Gillis, AM; Hii, JT; Mitchell, LB; Wyse, DG1
Bauernfeind, RA; Welch, WJ1
Grant, AO; Starmer, CF1
Funck-Brentano, C; Kroemer, HK; Pavlou, H; Roden, DM; Woosley, RL1
Bobbio, M; Bocchiardo, M; Gaita, F; Uslenghi, E; Vado, A1
Somberg, J1
Roden, DM; Siddoway, LA; Woosley, RL1
Amiel, A; Boutaud, P; Ciber, M; Demange, J; Guillem, JP; Herpin, D; Maarek-Charbit, M1
Huang, SK; Marcus, FI1
Allessie, MA; Bonke, FI; Lammers, WJ; Rensma, PL; Schalij, MJ1
Fenster, PE; Horwitz, L; Huang, SK; Kirsten, EB; Klein, RC; Marcus, FI; Rushforth, N1
Alboni, P; Candini, GC; Cappato, R; Paparella, N; Pirani, R1
Baker, BJ; deSoyza, N; Dinh, HA; Franciosa, JA; Murphy, ML1
Hirosawa, K; Kasanuki, H; Onishi, S1
Podrid, PJ1
Atarashi, H; Hayakawa, H1
Graboys, TB; Lampert, S; Lown, B; Podrid, PJ1
Schmitz, W1
Attuel, P; Coumel, P; Georgiopoulos, G; Halkidis, H; Leclercq, JF; Maisonblanche, P1
Somberg, JC1
Ceci, V; Di Marcotullio, G; Dini, P; Milazzotto, F; Polizzi, C; Santini, M1
Accettura, D; De Nicolò, M; De Toma, L; Lagioia, R; Mangini, SG; Rizzon, P; Scrutinio, D1
Assayag, P; Coumel, P; Leclercq, JF1
De Nicolò, M; De Toma, L; Lagioia, R; Mangini, SG; Rizzon, P; Scrutinio, D1
Ledda, F; Mantelli, L; Manzini, S; Mugelli, A1
Grey, E; Silverman, DI1
Bachernegg, M; Decrinis, M; Domanowits, H; Kickenweiz, E; Laggner, AN; Stark, G; Stark, U; Sterz, F; Tritthart, HA1
Fernández del Pozo, B; Pérez-Vizcaíno, F; Tamargo, J; Zaragozá, F1
Mörike, KE; Roden, DM1
Castle, NA; Slawsky, MT1
Boriani, G; Capucci, A; Della Casa, S; Magnani, B; Rubino, I; Sanguinetti, M1
Cowan, JC1
Lüderitz, B; Manz, M1
Brechenmacher, C; Chauvin, M; Koenig, A; Theolade, R1
Ebner, T; Eichelbaum, M1
Roden, DM1
Arrigo, F; Cavallaro, L; Coglitore, A; Fazio, F; Oreto, G; Saporito, F; Satullo, G; Sorrenti, S1
Chang, MS; Chen, SA; Chiang, CE; Lee, SH; Tai, CT; Wang, SP; Wen, ZC1
Di Benedetto, S1
Beurrier, D; Brembilla-Perrot, B; Danchin, N; Houplon, P; Jacquemin, L; Louis, P; Terrier de la Chaise, A1
Bellandi, F; Cantini, F; Dabizzi, RP; Mugnaioni, G; Palchetti, R1
Capucci, A1
Epstein, LM; Huang, DT; Josephson, ME; Monahan, KM; Papageorgiou, P; Zimetbaum, P1
Aschieri, D; Capucci, A; Piepoli, M; Villani, GQ1
Dell'Orfano, JT; Luck, JC; Naccarelli, GV; Patel, HM; Wolbrette, DL1
Ishii, K; Kubota, Y; Moriuchi, H; Nakahara, T; Sakamato, K; Shigenobu, K; Tanaka, Y; Yunoki, M1
Chow, MS; Fan, C; Lau, CP; Tang, MO; Tse, HF1
Hancox, JC; Paul, AA; Witchel, HJ1
Bhatta, L; Hynes, J; Khan, M; Luck, J; Naccarelli, GV; Samii, S; Wolbrette, DL1
Kao, W; Kowey, PR; Winkel, E; Yan, GX1
Furuichi, K; Inamura, K; Kitada, C; Matsushime, H; Miyake, A; Mochizuki, S; Nozawa, K; Okada, H; Sano, Y; Yokoi, H1
BORIS, A; MOE, RA; SCHALLEK, WE1
Borbély, M; Dani, G; Erdej, F; Hajdara, I; Katona, A; Márk, L; Nagy, E; Sziklai, G1
Dorian, P; Humphries, KH; Kerr, CR; Steinbuch, M1
Amor, F; Charisius, M; Plass, H; Turnheim, K; Wiener, H; Wyskovsky, W1
Iwaki, M; Komura, H1
Scharf, C1
Bakula, M; Frank, B; Gavranovic, Z; Milicevic, G; Pazur, V1
Daubert, JP1
Kochanowski, J; Kosior, DA; Opolski, G; Piatkowski, R; Postuła, M; Rabczenko, D; Scisło, P1
Champagne, J; Charbonneau, L; Geelen, P; Gilbert, M; Hamelin, BA; Michaud, V; O'Hara, GE; Philippon, F; Pruneau, G; Turgeon, J1
Bai, J; Gao, M; Lo, A; Lu, Y; Zhang, H; Zhao, J; Zhu, Y1
Belhassen, B; Biton, Y; Mowaswes, M1

Reviews

12 review(s) available for propafenone and quinidine

ArticleYear
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016
Antiarrhythmic drug therapy. Recent advances and current status.
    Cardiology, 1985, Volume: 72, Issue:5-6

    Topics: Adrenergic beta-Antagonists; Ajmaline; Amiodarone; Anilides; Anti-Arrhythmia Agents; Aprindine; Arrhythmias, Cardiac; Benzeneacetamides; Bepridil; Bethanidine; Bretylium Tosylate; Disopyramide; Drug Administration Schedule; Encainide; Flecainide; Heart Conduction System; Humans; Imidazoles; Lidocaine; Mexiletine; Moricizine; Myocardial Contraction; Phenothiazines; Phenytoin; Piperidines; Procainamide; Propafenone; Propiophenones; Pyrrolidines; Quinidine; Tocainide; Verapamil

1985
Clinical pharmacology of old and new antiarrhythmic drugs.
    Cardiovascular clinics, 1985, Volume: 15, Issue:3

    Topics: Adrenergic beta-Antagonists; Amiodarone; Anilides; Anti-Arrhythmia Agents; Benzeneacetamides; Biological Availability; Bretylium Compounds; Disopyramide; Encainide; Flecainide; Humans; Imipramine; Lidocaine; Mexiletine; Moricizine; Phenothiazines; Phenytoin; Piperidines; Procainamide; Propafenone; Propiophenones; Quinidine; Tocainide

1985
Antiarrhythmic drug therapy of ventricular arrhythmias.
    Current problems in cardiology, 1986, Volume: 11, Issue:4

    Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Bretylium Tosylate; Disopyramide; Flecainide; Heart Ventricles; Humans; Lidocaine; Mexiletine; Moricizine; Phenothiazines; Phenytoin; Piperidines; Procainamide; Propafenone; Propiophenones; Quinidine; Sotalol; Tocainide; Verapamil

1986
[Electrophysiological classification of newer antiarrhythmic drugs (author's transl)].
    Klinische Wochenschrift, 1980, Sep-15, Volume: 58, Issue:18

    Topics: Action Potentials; Adrenergic beta-Antagonists; Anilides; Animals; Anti-Arrhythmia Agents; Aprindine; Benzeneacetamides; Calcium; Disopyramide; Electrophysiology; Humans; Lidocaine; Mexiletine; Piperidines; Propafenone; Propiophenones; Quinidine; Sodium; Tocainide

1980
Supraventricular tachycardia and pre-excitation syndromes: pharmacological therapy.
    European heart journal, 1993, Volume: 14 Suppl E

    Topics: Ajmaline; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Disopyramide; Flecainide; Humans; Imidazoles; Pre-Excitation Syndromes; Propafenone; Quinidine; Sotalol; Tachycardia, Paroxysmal; Tachycardia, Supraventricular; Verapamil

1993
[Antiarrhythmic treatment after reduction of atrial fibrillation by external shock].
    Presse medicale (Paris, France : 1983), 1993, Nov-20, Volume: 22, Issue:36

    Topics: Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Combined Modality Therapy; Disopyramide; Electric Countershock; Flecainide; Humans; Propafenone; Quinidine; Recurrence; Sotalol

1993
Is there a need for new antiarrhythmic drugs?
    Archives des maladies du coeur et des vaisseaux, 1996, Volume: 89 Spec No 1

    Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Heart Conduction System; Humans; Propafenone; Quinidine; Sotalol; Torsades de Pointes

1996
Cost-effective management of acute atrial fibrillation: role of rate control, spontaneous conversion, medical and direct current cardioversion, transesophageal echocardiography, and antiembolic therapy.
    The American journal of cardiology, 2000, May-25, Volume: 85, Issue:10A

    Topics: Algorithms; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Cost-Benefit Analysis; Echocardiography, Transesophageal; Electric Countershock; Flecainide; Humans; Procainamide; Propafenone; Quinidine; Sotalol; Verapamil

2000
Old and new antiarrhythmic drugs for converting and maintaining sinus rhythm in atrial fibrillation: comparative efficacy and results of trials.
    The American journal of cardiology, 2003, Mar-20, Volume: 91, Issue:6A

    Topics: Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Australia; Canada; Controlled Clinical Trials as Topic; Europe; Flecainide; Heart Conduction System; Heart Failure; Humans; Multicenter Studies as Topic; Myocardial Infarction; Phenethylamines; Propafenone; Quinidine; Sotalol; Sulfonamides; Survival Analysis; Therapeutic Equivalency; Treatment Outcome; United States

2003
Pharmacologic and nonpharmacologic options to maintain sinus rhythm: guideline-based and new approaches.
    The American journal of cardiology, 2003, Mar-20, Volume: 91, Issue:6A

    Topics: Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Cardiac Pacing, Artificial; Catheter Ablation; Flecainide; Heart Rate; Humans; Phenethylamines; Practice Guidelines as Topic; Propafenone; Quinidine; Stroke; Sulfonamides; Ventricular Dysfunction, Left

2003
[Atrial flutter and fibrillation].
    Praxis, 2005, Nov-09, Volume: 94, Issue:45

    Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Adult; Aged; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Calcium Channel Blockers; Catheter Ablation; Clinical Trials as Topic; Disopyramide; Electric Countershock; Electrocardiography; Emergencies; Flecainide; Heart Rate; Humans; Middle Aged; Pacemaker, Artificial; Propafenone; Quinidine; Recurrence; Sotalol; Sulfonamides; Treatment Outcome; Vasodilator Agents

2005

Trials

15 trial(s) available for propafenone and quinidine

ArticleYear
[Propafenon in ventricular arrhythmia caused by ischemic cardiopathy. Quantitative study using the Holter system].
    Arquivos brasileiros de cardiologia, 1979, Volume: 33, Issue:4

    Topics: Administration, Oral; Adult; Aged; Cardiac Complexes, Premature; Clinical Trials as Topic; Female; Heart Ventricles; Humans; Male; Middle Aged; Myocardial Infarction; Perhexiline; Placebos; Propafenone; Propiophenones; Quinidine

1979
[Propafenone versus hydroquinidine in long-term pharmacological prophylaxis of atrial fibrillation].
    Cardiologia (Rome, Italy), 1992, Volume: 37, Issue:2

    Topics: Adult; Aged; Anti-Arrhythmia Agents; Atrial Fibrillation; Female; Follow-Up Studies; Humans; Male; Middle Aged; Propafenone; Prospective Studies; Quinidine; Time Factors

1992
Propafenone versus quinidine slow-release for the treatment of chronic ventricular arrhythmias.
    Acta cardiologica, 1990, Volume: 45, Issue:5

    Topics: Adult; Aged; Cardiac Complexes, Premature; Chronic Disease; Delayed-Action Preparations; Double-Blind Method; Electrocardiography, Ambulatory; Female; Heart Ventricles; Humans; Male; Metabolic Clearance Rate; Middle Aged; Propafenone; Quinidine; Tachycardia

1990
Efficacy of propafenone compared with quinidine in chronic ventricular arrhythmias.
    The American journal of cardiology, 1985, Jun-01, Volume: 55, Issue:13 Pt 1

    Topics: Adult; Aged; Arrhythmias, Cardiac; Clinical Trials as Topic; Double-Blind Method; Drug Tolerance; Humans; Male; Middle Aged; Propafenone; Propiophenones; Quinidine

1985
[Comparison of the efficacy of propafenone and hydroquinidine in stabilized extrasystolic ventricular arrhythmia by means of dynamic electrocardiographic Holter monitoring].
    Giornale italiano di cardiologia, 1984, Volume: 14, Issue:5

    Topics: Adolescent; Adult; Anti-Arrhythmia Agents; Cardiac Complexes, Premature; Double-Blind Method; Drug Administration Schedule; Drug Evaluation; Electrocardiography; Female; Humans; Male; Middle Aged; Propafenone; Propiophenones; Quinidine

1984
Holter monitoring comparative assessment of propafenone and dihydroquinidine efficacy in the treatment of premature ventricular beats.
    Cardiologia (Rome, Italy), 1983, Volume: 28, Issue:9

    Topics: Adolescent; Adult; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Clinical Trials as Topic; Electrocardiography; Female; Humans; Male; Middle Aged; Monitoring, Physiologic; Propafenone; Propiophenones; Quinidine; Time Factors

1983
Action of ATP on ventricular automaticity.
    Journal of cardiovascular pharmacology, 1994, Volume: 24, Issue:5

    Topics: Adenosine Triphosphate; Adrenergic beta-Antagonists; Ajmaline; Animals; Anti-Arrhythmia Agents; Austria; Cardiac Pacing, Artificial; Drug Interactions; Emergency Medical Services; Female; Guinea Pigs; Heart Ventricles; Humans; Injections, Intravenous; Male; Propafenone; Prospective Studies; Quinidine; Tachycardia, Supraventricular; Ventricular Function; Verapamil

1994
Quinidine-enhanced beta-blockade during treatment with propafenone in extensive metabolizer human subjects.
    Clinical pharmacology and therapeutics, 1994, Volume: 55, Issue:1

    Topics: Adrenergic beta-Antagonists; Adult; Cytochrome P-450 CYP2D6; Cytochrome P-450 Enzyme System; Double-Blind Method; Drug Synergism; Exercise; Female; Heart Rate; Humans; Isoproterenol; Male; Mixed Function Oxygenases; Phenotype; Propafenone; Quinidine; Stereoisomerism

1994
A controlled study on oral propafenone versus digoxin plus quinidine in converting recent onset atrial fibrillation to sinus rhythm.
    International journal of cardiology, 1994, Mar-01, Volume: 43, Issue:3

    Topics: Administration, Oral; Adult; Aged; Atrial Fibrillation; Digoxin; Drug Combinations; Electrocardiography, Ambulatory; Female; Heart Rate; Humans; Injections, Intravenous; Male; Middle Aged; Placebos; Propafenone; Quinidine; Remission Induction; Single-Blind Method; Ventricular Function

1994
[A comparison between propafenone and hydroquinidine perorally in the treatment of recent-onset atrial fibrillation].
    Minerva cardioangiologica, 1996, Volume: 44, Issue:3

    Topics: Administration, Oral; Adult; Aged; Anti-Arrhythmia Agents; Atrial Fibrillation; Drug Evaluation; Female; Heart Rate; Humans; Male; Middle Aged; Propafenone; Quinidine; Time Factors

1996
Comparisons of oral propafenone and quinidine as an initial treatment option in patients with symptomatic paroxysmal atrial fibrillation: a double-blind, randomized trial.
    Journal of internal medicine, 1996, Volume: 239, Issue:3

    Topics: Administration, Oral; Anti-Arrhythmia Agents; Atrial Fibrillation; Double-Blind Method; Electrocardiography; Female; Follow-Up Studies; Humans; Male; Middle Aged; Propafenone; Quinidine; Recurrence; Time Factors

1996
Safety of oral propafenone in the conversion of recent onset atrial fibrillation to sinus rhythm: a prospective parallel placebo-controlled multicentre study.
    International journal of cardiology, 1999, Feb-28, Volume: 68, Issue:2

    Topics: Administration, Oral; Anti-Arrhythmia Agents; Atrial Fibrillation; Digitalis Glycosides; Drug Therapy, Combination; Electrocardiography, Ambulatory; Female; Follow-Up Studies; Heart Rate; Humans; Male; Middle Aged; Propafenone; Prospective Studies; Quinidine; Safety; Treatment Outcome

1999
Control of paroxysmal atrial fibrillation recurrence using combined administration of propafenone and quinidine.
    The American journal of cardiology, 2000, Dec-15, Volume: 86, Issue:12

    Topics: Adolescent; Adult; Aged; Analysis of Variance; Anti-Arrhythmia Agents; Atrial Fibrillation; Cross-Over Studies; Dose-Response Relationship, Drug; Double-Blind Method; Drug Combinations; Female; Humans; Male; Middle Aged; Propafenone; Prospective Studies; Quinidine; Recurrence; Safety; Treatment Outcome

2000
Efficacy and tolerability of oral propafenone versus quinidine in the treatment of recent onset atrial fibrillation: A randomized, prospective study.
    Cardiology journal, 2009, Volume: 16, Issue:6

    Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Anti-Arrhythmia Agents; Atrial Fibrillation; Blood Pressure; Digoxin; Drug Therapy, Combination; Electrocardiography, Ambulatory; Female; Heart Conduction System; Heart Rate; Humans; Injections, Intravenous; Male; Middle Aged; Propafenone; Prospective Studies; Quinidine; Recurrence; Time Factors; Treatment Outcome

2009
Combined administration of quinidine and propafenone for atrial fibrillation: the CAQ-PAF study.
    Journal of clinical pharmacology, 2012, Volume: 52, Issue:2

    Topics: Aged; Anti-Arrhythmia Agents; Atrial Fibrillation; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP2D6 Inhibitors; Double-Blind Method; Drug Therapy, Combination; Female; Genotype; Heart Rate; Humans; Male; Middle Aged; Propafenone; Quinidine

2012

Other Studies

68 other study(ies) available for propafenone and quinidine

ArticleYear
QSAR model for drug human oral bioavailability.
    Journal of medicinal chemistry, 2000, Jun-29, Volume: 43, Issue:13

    Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship

2000
ElogD(oct): a tool for lipophilicity determination in drug discovery. 2. Basic and neutral compounds.
    Journal of medicinal chemistry, 2001, Jul-19, Volume: 44, Issue:15

    Topics: 1-Octanol; Chromatography, High Pressure Liquid; Pharmaceutical Preparations; Solubility; Water

2001
Prediction of volume of distribution values in humans for neutral and basic drugs using physicochemical measurements and plasma protein binding data.
    Journal of medicinal chemistry, 2002, Jun-20, Volume: 45, Issue:13

    Topics: Blood Proteins; Chemical Phenomena; Chemistry, Physical; Half-Life; Humans; Hydrogen-Ion Concentration; Models, Biological; Pharmaceutical Preparations; Pharmacokinetics; Protein Binding

2002
Pharmacophore model of drugs involved in P-glycoprotein multidrug resistance: explanation of structural variety (hypothesis).
    Journal of medicinal chemistry, 2002, Dec-19, Volume: 45, Issue:26

    Topics: Adenosine Triphosphatases; Algorithms; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Binding Sites; Binding, Competitive; Caco-2 Cells; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Fluoresceins; Humans; Ligands; Models, Molecular; Molecular Structure; Quantitative Structure-Activity Relationship; Radioligand Assay; Rhodamine 123; Stereoisomerism; Verapamil; Vinblastine

2002
Prediction of human volume of distribution values for neutral and basic drugs. 2. Extended data set and leave-class-out statistics.
    Journal of medicinal chemistry, 2004, Feb-26, Volume: 47, Issue:5

    Topics: Algorithms; Blood Proteins; Half-Life; Humans; Hydrogen-Ion Concentration; Models, Biological; Pharmaceutical Preparations; Pharmacokinetics; Protein Binding; Statistics as Topic; Tissue Distribution

2004
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
    Current drug discovery technologies, 2004, Volume: 1, Issue:4

    Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration

2004
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
    Drug metabolism and disposition: the biological fate of chemicals, 2008, Volume: 36, Issue:7

    Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding

2008
Prediction and identification of drug interactions with the human ATP-binding cassette transporter multidrug-resistance associated protein 2 (MRP2; ABCC2).
    Journal of medicinal chemistry, 2008, Jun-12, Volume: 51, Issue:11

    Topics: Administration, Oral; Animals; Antineoplastic Agents; Antipsychotic Agents; Antiviral Agents; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Biological Transport; Cell Line; Computer Simulation; Cytochrome P-450 Enzyme System; Drug-Related Side Effects and Adverse Reactions; Estradiol; Humans; Insecta; Liver; Models, Molecular; Multidrug Resistance-Associated Protein 2; Multidrug Resistance-Associated Proteins; Neoplasm Proteins; Pharmaceutical Preparations; Pharmacology; Structure-Activity Relationship

2008
In silico activity profiling reveals the mechanism of action of antimalarials discovered in a high-throughput screen.
    Proceedings of the National Academy of Sciences of the United States of America, 2008, Jul-01, Volume: 105, Issue:26

    Topics: Animals; Antimalarials; Cluster Analysis; Computational Biology; Drug Evaluation, Preclinical; Drug Resistance; Folic Acid Antagonists; Malaria; Models, Molecular; Parasites; Plasmodium falciparum; Reproducibility of Results; Structure-Activity Relationship; Tetrahydrofolate Dehydrogenase

2008
Determination of log D via automated microfluidic liquid-liquid extraction.
    Journal of medicinal chemistry, 2008, Aug-28, Volume: 51, Issue:16

    Topics: Automation; Biopharmaceutics; Microfluidic Analytical Techniques; Pharmacokinetics

2008
Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1.
    Journal of medicinal chemistry, 2008, Oct-09, Volume: 51, Issue:19

    Topics: Cell Line; Computer Simulation; Drug Design; Gene Expression Profiling; Humans; Hydrogen Bonding; Liver; Molecular Weight; Organic Cation Transporter 1; Pharmaceutical Preparations; Predictive Value of Tests; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Structure-Activity Relationship

2008
Prediction of volume of distribution values in human using immobilized artificial membrane partitioning coefficients, the fraction of compound ionized and plasma protein binding data.
    European journal of medicinal chemistry, 2009, Volume: 44, Issue:11

    Topics: Blood Proteins; Chemistry, Physical; Computer Simulation; Humans; Membranes, Artificial; Models, Biological; Pharmaceutical Preparations; Protein Binding; Tissue Distribution

2009
Simulation of multiple ion channel block provides improved early prediction of compounds' clinical torsadogenic risk.
    Cardiovascular research, 2011, Jul-01, Volume: 91, Issue:1

    Topics: Action Potentials; Animals; Calcium Channel Blockers; Calcium Channels, L-Type; Computer Simulation; Dogs; Dose-Response Relationship, Drug; ERG1 Potassium Channel; Ether-A-Go-Go Potassium Channels; Guinea Pigs; HEK293 Cells; Humans; Ion Channels; Kinetics; Models, Cardiovascular; NAV1.5 Voltage-Gated Sodium Channel; Patch-Clamp Techniques; Potassium Channel Blockers; Rabbits; Risk Assessment; Risk Factors; Sodium Channel Blockers; Sodium Channels; Torsades de Pointes; Transfection

2011
Comparison of cryopreserved HepaRG cells with cryopreserved human hepatocytes for prediction of clearance for 26 drugs.
    Drug metabolism and disposition: the biological fate of chemicals, 2012, Volume: 40, Issue:1

    Topics: Cell Line, Tumor; Cryopreservation; Female; Hepatocytes; Humans; Male; Metabolic Clearance Rate; Pharmaceutical Preparations; Predictive Value of Tests

2012
Imaging of Plasmodium liver stages to drive next-generation antimalarial drug discovery.
    Science (New York, N.Y.), 2011, Dec-09, Volume: 334, Issue:6061

    Topics: Animals; Antimalarials; Cell Line, Tumor; Drug Discovery; Drug Evaluation, Preclinical; Drug Resistance; Erythrocytes; Humans; Imidazoles; Liver; Malaria; Mice; Mice, Inbred BALB C; Molecular Structure; Piperazines; Plasmodium; Plasmodium berghei; Plasmodium falciparum; Plasmodium yoelii; Polymorphism, Single Nucleotide; Protozoan Proteins; Random Allocation; Small Molecule Libraries; Sporozoites

2011
Predictive model for L-type channel inhibition: multichannel block in QT prolongation risk assessment.
    Journal of applied toxicology : JAT, 2012, Volume: 32, Issue:10

    Topics: Artificial Intelligence; Calcium Channel Blockers; Calcium Channels, L-Type; Cell Line; Computational Biology; Computer Simulation; Drugs, Investigational; Ether-A-Go-Go Potassium Channels; Expert Systems; Heart Rate; Humans; Models, Biological; Myocytes, Cardiac; NAV1.5 Voltage-Gated Sodium Channel; Potassium Channel Blockers; Quantitative Structure-Activity Relationship; Risk Assessment; Shaker Superfamily of Potassium Channels; Torsades de Pointes; Voltage-Gated Sodium Channel Blockers

2012
Which metabolites circulate?
    Drug metabolism and disposition: the biological fate of chemicals, 2013, Volume: 41, Issue:5

    Topics: Humans; Metabolic Clearance Rate; Pharmaceutical Preparations

2013
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
    Toxicological sciences : an official journal of the Society of Toxicology, 2013, Volume: 136, Issue:1

    Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests

2013
Comparison of the accuracy of experimental and predicted pKa values of basic and acidic compounds.
    Pharmaceutical research, 2014, Volume: 31, Issue:4

    Topics: Chemistry, Pharmaceutical; Forecasting; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Random Allocation

2014
Discovery and Characterization of Fluorine-Substituted Diarylpyrimidine Derivatives as Novel HIV-1 NNRTIs with Highly Improved Resistance Profiles and Low Activity for the hERG Ion Channel.
    Journal of medicinal chemistry, 2020, 02-13, Volume: 63, Issue:3

    Topics: Animals; Anti-HIV Agents; Cell Line; Crystallography, X-Ray; Drug Discovery; ERG1 Potassium Channel; Female; Fluorine; HIV Reverse Transcriptase; HIV-1; Humans; Male; Mice; Microsomes, Liver; Molecular Structure; Protein Binding; Pyrimidines; Rats, Wistar; Reverse Transcriptase Inhibitors; Structure-Activity Relationship; Thiophenes

2020
Identification of C5-NH
    Journal of medicinal chemistry, 2021, 12-23, Volume: 64, Issue:24

    Topics: Animals; Antiviral Agents; Biological Availability; Chick Embryo; Computer Simulation; Half-Life; Influenza A Virus, H5N1 Subtype; Mice; Molecular Docking Simulation; Molecular Dynamics Simulation; Neuraminidase; Oseltamivir; Rats; Rats, Sprague-Dawley; Structure-Activity Relationship

2021
[Anti-arrhythmia agents in heart failure].
    Kardiologiia, 1992, Volume: 32, Issue:4

    Topics: Adult; Aged; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Cardiac Pacing, Artificial; Cardiomyopathy, Dilated; Flecainide; Humans; Mexiletine; Middle Aged; Propafenone; Quinidine

1992
[Effects of propafenone, quinidine, and their combination on ventricular fibrillation threshold in dogs].
    Zhongguo yao li xue bao = Acta pharmacologica Sinica, 1992, Volume: 13, Issue:4

    Topics: Animals; Blood Pressure; Dogs; Drug Therapy, Combination; Female; Male; Propafenone; Quinidine; Ventricular Fibrillation

1992
Is pretransplant antiarrhythmic drug therapy a risk factor?
    Transplantation proceedings, 1992, Volume: 24, Issue:6

    Topics: Adolescent; Adult; Aged; Amiodarone; Anti-Arrhythmia Agents; Aprindine; Cause of Death; Child; Female; Follow-Up Studies; Heart Transplantation; Humans; Male; Mexiletine; Middle Aged; Postoperative Complications; Premedication; Propafenone; Quinidine; Sotalol; Survival Rate; Transplantation, Heterotopic

1992
Responsiveness of cardiac Na+ channels to antiarrhythmic drugs: the role of inactivation.
    The Journal of membrane biology, 1991, Volume: 122, Issue:3

    Topics: Animals; Anti-Arrhythmia Agents; Cells, Cultured; Dose-Response Relationship, Drug; Fluorides; Heart; Heart Rate; Lidocaine; Myocardium; Propafenone; Quinidine; Sodium Channels

1991
Myocardial uptake and pharmacodynamics of quinidine and propafenone in isolated rabbit hearts: metabolic versus respiratory acidosis.
    Journal of cardiovascular pharmacology, 1991, Volume: 17, Issue:4

    Topics: Acidosis; Acidosis, Respiratory; Animals; Coronary Circulation; Electrocardiography; Heart; Hydrogen-Ion Concentration; In Vitro Techniques; Male; Myocardium; Propafenone; Quinidine; Rabbits

1991
Propafenone-induced torsade de pointes: cross-reactivity with quinidine.
    Pacing and clinical electrophysiology : PACE, 1991, Volume: 14, Issue:11 Pt 1

    Topics: Aged; Anti-Arrhythmia Agents; Atrial Fibrillation; Cross Reactions; Electrocardiography; Female; Humans; Propafenone; Quinidine; Torsades de Pointes

1991
New hope in atrial fibrillation.
    Journal of the American College of Cardiology, 1990, Mar-01, Volume: 15, Issue:3

    Topics: Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Humans; Propafenone; Quinidine; Sotalol

1990
Phasic ion channel blockade. A kinetic model and parameter estimation procedure.
    Molecular pharmacology, 1985, Volume: 28, Issue:4

    Topics: Animals; Binding Sites; Biological Transport; Electric Stimulation; In Vitro Techniques; Ion Channels; Kinetics; Lidocaine; Membrane Potentials; Muscles; Propafenone; Propiophenones; Quinidine; Solubility; Stochastic Processes

1985
Genetically-determined interaction between propafenone and low dose quinidine: role of active metabolites in modulating net drug effect.
    British journal of clinical pharmacology, 1989, Volume: 27, Issue:4

    Topics: Adult; Aged; Arrhythmias, Cardiac; Biotransformation; Electrocardiography; Female; Humans; Hydroxylation; Male; Middle Aged; Phenotype; Propafenone; Quinidine

1989
[Control of the efficacy of anti-arrhythmia drug therapy with the ambulatory electrocardiogram. Proposal for a new analytical statistical model].
    Giornale italiano di cardiologia, 1985, Volume: 15, Issue:2

    Topics: Adrenergic beta-Antagonists; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Electrocardiography; Humans; Propafenone; Propiophenones; Prospective Studies; Quinidine; Retrospective Studies

1985
[Anti-arrhythmia efficacy of propafenone per os in the prevention of paroxysmal supraventricular arrhythmia resistant to class Ia agents].
    Annales de cardiologie et d'angeiologie, 1989, Volume: 38, Issue:1

    Topics: Administration, Oral; Aged; Disopyramide; Drug Evaluation; Drug Resistance; Female; Humans; Male; Middle Aged; Propafenone; Quinidine; Tachycardia, Paroxysmal; Tachycardia, Supraventricular

1989
Length of excitation wave and susceptibility to reentrant atrial arrhythmias in normal conscious dogs.
    Circulation research, 1988, Volume: 62, Issue:2

    Topics: Acetylcholine; Animals; Arrhythmias, Cardiac; Autonomic Nervous System; Dogs; Female; Heart Conduction System; Lidocaine; Male; Neural Conduction; Ouabain; Physical Exertion; Propafenone; Quinidine; Refractory Period, Electrophysiological; Sotalol

1988
Enhanced antiarrhythmic efficacy of propafenone when used in combination with procainamide or quinidine.
    American heart journal, 1987, Volume: 114, Issue:3

    Topics: Adult; Aged; Anti-Arrhythmia Agents; Drug Synergism; Drug Therapy, Combination; Electrocardiography; Female; Humans; Male; Middle Aged; Procainamide; Propafenone; Quinidine; Stroke Volume

1987
[Method for differentiating in humans the direct effects of anti-arrhythmic drugs from those mediated by the autonomic nervous system. Effects of quinidine and propafenone].
    Giornale italiano di cardiologia, 1986, Volume: 16, Issue:9

    Topics: Adolescent; Adult; Aged; Atrioventricular Node; Autonomic Nervous System; Electrocardiography; Female; Heart Conduction System; Humans; Male; Middle Aged; Propafenone; Quinidine; Sinoatrial Node

1986
The usefulness of electrophysiological-pharmacologic studies in the long-term therapy of paroxysmal tachycardias.
    Japanese circulation journal, 1985, Volume: 49, Issue:3

    Topics: Administration, Oral; Adolescent; Adult; Aged; Anti-Arrhythmia Agents; Cardiomyopathies; Chromatography, High Pressure Liquid; Disopyramide; Electric Stimulation; Electrocardiography; Female; Humans; Lidocaine; Male; Mexiletine; Middle Aged; Myocardial Infarction; Propafenone; Propiophenones; Quinidine; Tachycardia, Paroxysmal; Time Factors; Tocainide; Verapamil

1985
Aggravation of ventricular arrhythmia. A drug-induced complication.
    Drugs, 1985, Volume: 29 Suppl 4

    Topics: Anilides; Anti-Arrhythmia Agents; Aprindine; Arrhythmias, Cardiac; Disopyramide; Drug Evaluation; Electrocardiography; Encainide; Flecainide; Humans; Mexiletine; Piperidines; Procainamide; Propafenone; Propiophenones; Quinidine

1985
[Anti-arrhythmia agents (I): Quinidine, procainamide, disopyramide, encainide, propafenone and flecainide].
    Nihon rinsho. Japanese journal of clinical medicine, 1985, Volume: 43, Issue:11

    Topics: Anilides; Anti-Arrhythmia Agents; Disopyramide; Encainide; Flecainide; Humans; Piperidines; Procainamide; Propafenone; Propiophenones; Quinidine

1985
Use of short-term drug testing as part of a systematic approach for evaluation of antiarrhythmic drugs.
    Circulation, 1986, Volume: 73, Issue:2 Pt 2

    Topics: Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Drug Evaluation; Electric Stimulation; Humans; Monitoring, Physiologic; Procainamide; Prognosis; Propafenone; Propiophenones; Quinidine; Time Factors

1986
[Effects of anti-arrhythmia agents on heart rate. Significance and importance].
    Archives des maladies du coeur et des vaisseaux, 1981, Volume: 74 Spec No

    Topics: Adrenergic beta-Antagonists; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Atrial Fibrillation; Disopyramide; Electrocardiography; Heart Conduction System; Heart Rate; Humans; Lidocaine; Propafenone; Propiophenones; Quinidine; Verapamil

1981
New directions in antiarrhythmic drug therapy.
    The American journal of cardiology, 1984, Aug-13, Volume: 54, Issue:4

    Topics: Adrenergic beta-Antagonists; Ajmaline; Amiodarone; Anilides; Anti-Arrhythmia Agents; Aprindine; Benzeneacetamides; Bepridil; Bethanidine; Bretylium Tosylate; Death, Sudden; Disopyramide; Encainide; Flecainide; Humans; Lidocaine; Mexiletine; Moricizine; Phenothiazines; Piperidines; Procainamide; Propafenone; Propiophenones; Pyrrolidines; Quinidine; Tachycardia; Tocainide; Verapamil

1984
[Combinations of some anti-arrhythmia drugs].
    Giornale italiano di cardiologia, 1984, Volume: 14, Issue:5

    Topics: Adrenergic beta-Antagonists; Amiodarone; Anti-Arrhythmia Agents; Digoxin; Drug Therapy, Combination; Humans; Mexiletine; Propafenone; Propiophenones; Quinidine

1984
European experience with the antiarrhythmic efficacy of propafenone for supraventricular and ventricular arrhythmias.
    The American journal of cardiology, 1984, Nov-14, Volume: 54, Issue:9

    Topics: Adolescent; Adult; Aged; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Atrial Fibrillation; Atrial Flutter; Autonomic Nervous System; Cardiac Complexes, Premature; Child; Drug Therapy, Combination; Electrocardiography; Female; Heart Ventricles; Humans; Male; Middle Aged; Propafenone; Propiophenones; Quinidine; Tachycardia; Wolff-Parkinson-White Syndrome

1984
The influence of some cardiodepressant drugs on the histamine-induced restoration of contractility in potassium-depolarized heart preparations.
    Archives internationales de pharmacodynamie et de therapie, 1981, Volume: 254, Issue:1

    Topics: Animals; Calcium Channel Blockers; Depression, Chemical; Guinea Pigs; Histamine; In Vitro Techniques; Lidocaine; Male; Myocardial Contraction; Potassium; Propafenone; Propiophenones; Quinidine; Thiopental

1981
Efficacy of type 1C antiarrhythmic agents for treatment of resistant atrial fibrillation.
    Pacing and clinical electrophysiology : PACE, 1993, Volume: 16, Issue:12

    Topics: Aged; Anti-Arrhythmia Agents; Atrial Fibrillation; Disopyramide; Encainide; Female; Flecainide; Heart Rate; Humans; Male; Middle Aged; Procainamide; Propafenone; Quinidine; Recurrence; Retrospective Studies

1993
Chemically modified cardiac Na+ channels and their sensitivity to antiarrhythmics: is there a hidden drug receptor?
    The Journal of membrane biology, 1994, Volume: 139, Issue:3

    Topics: Animals; Anti-Arrhythmia Agents; Biological Transport; Cells, Cultured; Iodates; Lidocaine; Myocardium; Prajmaline; Propafenone; Quinidine; Rats; Receptors, Drug; Sodium Channels; Trypsin

1994
Voltage- and time-dependent inhibitory effects on rat aortic and porcine coronary artery contraction induced by propafenone and quinidine.
    British journal of pharmacology, 1994, Volume: 113, Issue:4

    Topics: Animals; Aorta, Thoracic; Calcium; Calcium Radioisotopes; Coronary Vessels; Electrophysiology; In Vitro Techniques; Male; Muscle Contraction; Muscle, Smooth, Vascular; Potassium Chloride; Propafenone; Quinidine; Rats; Rats, Sprague-Dawley; Swine; Time Factors

1994
K+ channel blocking actions of flecainide compared with those of propafenone and quinidine in adult rat ventricular myocytes.
    The Journal of pharmacology and experimental therapeutics, 1994, Volume: 269, Issue:1

    Topics: Animals; Anti-Arrhythmia Agents; Cells, Cultured; Electrophysiology; Flecainide; Heart; Heart Ventricles; Kinetics; Potassium Channels; Propafenone; Quinidine; Rats; Rats, Sprague-Dawley; Sensitivity and Specificity

1994
Antiarrhythmic drugs in the management of atrial fibrillation.
    British heart journal, 1993, Volume: 70, Issue:4

    Topics: Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Digoxin; Flecainide; Heart; Humans; Propafenone; Quinidine

1993
The metabolism of aprindine in relation to the sparteine/debrisoquine polymorphism.
    British journal of clinical pharmacology, 1993, Volume: 35, Issue:4

    Topics: Aprindine; Cytochrome P-450 CYP2D6; Cytochrome P-450 Enzyme System; Debrisoquin; Humans; Hydroxylation; Kinetics; Microsomes, Liver; Mixed Function Oxygenases; Polymorphism, Genetic; Propafenone; Quinidine; Sparteine

1993
Quinidine versus propafenone for conversion of atrial fibrillation to sinus rhythm.
    The American journal of cardiology, 1997, Aug-15, Volume: 80, Issue:4

    Topics: Administration, Oral; Aged; Anti-Arrhythmia Agents; Atrial Fibrillation; Female; Heart Rate; Humans; Male; Middle Aged; Propafenone; Quinidine; Treatment Outcome

1997
[Can 1/1 atrial flutter be foreseen by class I anti-arrhythmics?].
    Archives des maladies du coeur et des vaisseaux, 1997, Volume: 90, Issue:7

    Topics: Aged; Anti-Arrhythmia Agents; Atrial Flutter; Disopyramide; Electrocardiography; Female; Flecainide; Heart Conduction System; Humans; Imidazoles; Male; Middle Aged; Predictive Value of Tests; Propafenone; Quinidine; Risk Factors

1997
[Pharmacological cardioversion of isolated atrial fibrillation: recovery of atrial mechanical function and correlation with duration of arrhythmia].
    Giornale italiano di cardiologia, 1997, Volume: 27, Issue:10

    Topics: Adult; Aged; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Function; Data Interpretation, Statistical; Echocardiography, Doppler, Pulsed; Female; Flecainide; Follow-Up Studies; Hemodynamics; Humans; Male; Middle Aged; Propafenone; Quinidine; Recurrence; Time Factors

1997
Quinidine versus propafenone for conversion of atrial fibrillation to sinus rhythm.
    The American journal of cardiology, 1998, Feb-01, Volume: 81, Issue:3

    Topics: Anti-Arrhythmia Agents; Atrial Fibrillation; Heart Rate; Humans; Propafenone; Quinidine; Treatment Outcome

1998
Hybrid pharmacologic and ablative therapy: a novel and effective approach for the management of atrial fibrillation.
    Journal of cardiovascular electrophysiology, 1998, Volume: 9, Issue:5

    Topics: Adult; Aged; Aged, 80 and over; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Catheter Ablation; Flecainide; Follow-Up Studies; Humans; Male; Middle Aged; Propafenone; Quinidine

1998
Involvement of K(+) channel in procainamide-induced relaxation of bovine tracheal smooth muscle.
    European journal of pharmacology, 2000, Aug-18, Volume: 402, Issue:1-2

    Topics: Albuterol; Animals; Anti-Arrhythmia Agents; Bronchoconstrictor Agents; Bronchodilator Agents; Cattle; In Vitro Techniques; Methacholine Chloride; Mexiletine; Muscle Contraction; Muscle Relaxation; Muscle, Smooth; Potassium; Potassium Channels; Procainamide; Propafenone; Quinidine; Trachea

2000
Inhibition of the current of heterologously expressed HERG potassium channels by flecainide and comparison with quinidine, propafenone and lignocaine.
    British journal of pharmacology, 2002, Volume: 136, Issue:5

    Topics: Cation Transport Proteins; DNA-Binding Proteins; Dose-Response Relationship, Drug; ERG1 Potassium Channel; Ether-A-Go-Go Potassium Channels; Flecainide; Humans; Lidocaine; Neural Inhibition; Potassium Channels; Potassium Channels, Voltage-Gated; Propafenone; Quinidine; Trans-Activators; Transcriptional Regulator ERG

2002
A novel two-pore domain K+ channel, TRESK, is localized in the spinal cord.
    The Journal of biological chemistry, 2003, Jul-25, Volume: 278, Issue:30

    Topics: Amino Acid Sequence; Analgesics, Non-Narcotic; Animals; Anti-Arrhythmia Agents; Arachidonic Acid; Barium; Cell Line; Cloning, Molecular; Docosahexaenoic Acids; Electrophysiology; Ethanolamines; Fatty Acids; Fatty Acids, Nonesterified; Glyburide; Humans; Hydrogen-Ion Concentration; Lidocaine; Mice; Models, Biological; Molecular Sequence Data; Patch-Clamp Techniques; Phylogeny; Potassium Channels; Propafenone; Protein Structure, Tertiary; Quinidine; Quinine; Reverse Transcriptase Polymerase Chain Reaction; Spinal Cord; Tissue Distribution; Transfection

2003
A comparison of some cardiac responses to Ro 2-5803 (Rythmol), quinidine and procaine amide in laboratory animals.
    Journal of the American Geriatrics Society, 1961, Volume: 9

    Topics: Animals; Animals, Laboratory; Anti-Arrhythmia Agents; Procainamide; Propafenone; Quinidine

1961
Atrial fibrillation: rate control often better than rhythm control.
    Prescrire international, 2004, Volume: 13, Issue:70

    Topics: Adult; Aged; Amiodarone; Anticoagulants; Arrhythmia, Sinus; Atrial Fibrillation; Canada; Disopyramide; Electric Countershock; Flecainide; Heart Rate; Humans; Netherlands; Platelet Aggregation Inhibitors; Propafenone; Quinidine; Sotalol; United States

2004
[Treatment of atrial fibrillation in a Hungarian hospital department of cardiologic internal medicine at the turn of the millennium].
    Orvosi hetilap, 2004, May-09, Volume: 145, Issue:19

    Topics: Acute Disease; Adrenergic beta-Antagonists; Aged; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Cardiology Service, Hospital; Electric Countershock; Female; Follow-Up Studies; Hospital Departments; Humans; Hungary; Male; Middle Aged; Prajmaline; Propafenone; Quinidine; Retrospective Studies; Sotalol

2004
Limitations to antiarrhythmic drug use in patients with atrial fibrillation.
    CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne, 2004, Sep-28, Volume: 171, Issue:7

    Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Canada; Contraindications; Female; Flecainide; Humans; Male; Middle Aged; Propafenone; Quinidine; Registries; Sotalol

2004
Class I antiarrhythmics inhibit Na+ absorption and Cl- secretion in rabbit descending colon epithelium.
    Naunyn-Schmiedeberg's archives of pharmacology, 2005, Volume: 371, Issue:6

    Topics: Animals; Anti-Arrhythmia Agents; Chlorides; Colon, Descending; Electric Conductivity; Female; In Vitro Techniques; Intestinal Mucosa; Potassium; Potassium Channels, Calcium-Activated; Propafenone; Quinidine; Rabbits; Sodium

2005
Usefulness of hepatocytes for evaluating the genetic polymorphism of CYP2D6 substrates.
    Xenobiotica; the fate of foreign compounds in biological systems, 2005, Volume: 35, Issue:6

    Topics: Cells, Cultured; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP2D6 Inhibitors; Enzyme Inhibitors; Genetic Techniques; Hepatocytes; Humans; Metoprolol; Microsomes, Liver; Polymorphism, Genetic; Propafenone; Propranolol; Quinidine

2005
Successful conversion of recent-onset atrial fibrillation by sequential administration of up to three antiarrhythmic drugs.
    Clinical cardiology, 2008, Volume: 31, Issue:10

    Topics: Adult; Aged; Aged, 80 and over; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Drug Administration Schedule; Electric Countershock; Electrocardiography; Female; Follow-Up Studies; Heart Rate; Humans; Infusions, Intravenous; Male; Middle Aged; Propafenone; Prospective Studies; Quinidine; Treatment Outcome; Young Adult

2008
Is newer better? Propafenone versus quinidine for conversion of atrial fibrillation.
    Cardiology journal, 2009, Volume: 16, Issue:6

    Topics: Administration, Oral; Anti-Arrhythmia Agents; Atrial Fibrillation; Digoxin; Drug Therapy, Combination; Heart Conduction System; Humans; Injections, Intravenous; Propafenone; Quinidine; Recurrence; Time Factors; Treatment Outcome

2009
In Silico Assessment of Class I Antiarrhythmic Drug Effects on
    International journal of molecular sciences, 2021, Jan-27, Volume: 22, Issue:3

    Topics: Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Atrial Fibrillation; Computer Simulation; Disopyramide; Heart Atria; Homeobox Protein PITX2; Homeodomain Proteins; Humans; Mice; Propafenone; Quinidine; Transcription Factors

2021
Type 1 Brugada-Electrocardiogram: A Rare Presentation in a 57-Year-Old Woman with Paroxysmal Atrial Fibrillation Treated with a Therapeutic Dose of Propafenone.
    The Israel Medical Association journal : IMAJ, 2021, Volume: 23, Issue:7

    Topics: Anti-Arrhythmia Agents; Atrial Fibrillation; Brugada Syndrome; Clinical Decision-Making; Drug Substitution; Echocardiography; Electric Countershock; Female; Humans; Middle Aged; Propafenone; Quinidine; Treatment Outcome

2021